Chemical formula: C₁₀H₁₆N₆S Molecular mass: 252.339 g/mol PubChem compound: 2756
Cimetidine is indicated for:
Population group: only adults (18 years old or older)
Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Persistent dyspeptic symptoms with or without ulceration, particularly meal-related upper abdominal pain, including such symptoms associated with non-steroidal anti-inflammatory agents.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Cimetidine is recommended before general anaesthesia in patients thought to be at risk of acid aspiration (Mendelson’s Syndrome), particularly obstetric patients during labour.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Cimetidine is recommended to reduce malabsorption and fluid loss in the short bowel syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Cimetidine is recommended in pancreatic insufficiency to reduce degradation of enzyme supplements.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Cimetidine is recommended in the management of the Zollinger-Ellison syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old)
Cimetidine is recommended in the management of the Zollinger-Ellison syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old)
Cimetidine is recommended in pancreatic insufficiency to reduce degradation of enzyme supplements.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old)
Cimetidine is recommended to reduce malabsorption and fluid loss in the short bowel syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old)
Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Cimetidine is recommended in the management of the Zollinger-Ellison syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Cimetidine is recommended in pancreatic insufficiency to reduce degradation of enzyme supplements.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Cimetidine is recommended to reduce malabsorption and fluid loss in the short bowel syndrome.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Cimetidine is indicated in the treatment of duodenal and benign gastric ulceration.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Cimetidine is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
